Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The IGF2BP3-COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression. | Cancer Res | 2023 | 37560971 | PubTator, text mining | PubMed |
| Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors. | Theranostics | 2023 | 37554271 | PubTator, text mining | PubMed |
| Circulating circRNA: a social butterfly in tumors. | Front Oncol | 2023 | 37546422 | PubTator, text mining | PubMed |
| Biological function and research progress of N6-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers. | Front Oncol | 2023 | 37546413 | PubTator, text mining | PubMed |
| hsa_circ_0010889 downregulation inhibits malignant glioma progression by modulating the miR-590-5p/SATB1 axis. | Aging (Albany NY) | 2023 | 37540226 | PubTator, text mining | PubMed |
| METTL14‑mediated RNA methylation in digestive system tumors. | Int J Mol Med | 2023 | 37539726 | PubTator, text mining | PubMed |
| Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. | Clin Transl Med | 2023 | 37537731 | PubTator, text mining | PubMed |
| Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma. | BMC Pulm Med | 2023 | 37537521 | PubTator, text mining | PubMed |
| Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. | J Hematol Oncol | 2023 | 37533128 | PubTator, text mining | PubMed |
| Recent advances of exosomal circRNAs in cancer and their potential clinical applications. | J Transl Med | 2023 | 37525158 | PubTator, text mining | PubMed |
| IGF2BP1-An Oncofetal RNA-Binding Protein Fuels Tumor Virus Propagation. | Viruses | 2023 | 37515119 | PubTator, text mining | PubMed |
| Comprehensive Analysis and Drug Modulation of Human Endogenous Retrovirus in Hepatocellular Carcinomas. | Cancers (Basel) | 2023 | 37509325 | PubTator, text mining | PubMed |
| IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment. | Front Immunol | 2023 | 37503349 | PubTator, text mining | PubMed |
| Characterization of epitranscriptome reader proteins experimentally and in silico: Current knowledge and future perspectives beyond the YTH domain. | Comput Struct Biotechnol J | 2023 | 37501707 | PubTator, text mining | PubMed |
| Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis. | Int J Biol Sci | 2023 | 37497000 | PubTator, text mining | PubMed |
| FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway. | Int J Biol Sci | 2023 | 37496990 | PubTator, text mining | PubMed |
| Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | 37492716 | PubTator, text mining | PubMed |
| Functions of Circular RNA in Human Diseases and Illnesses. | Noncoding RNA | 2023 | 37489458 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism. | Front Endocrinol (Lausanne) | 2023 | 37484964 | PubTator, text mining | PubMed |
| The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 37484960 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=32